Heparanase and COX-2 expression as predictors of lymph node metastasis in large, high-grade breast tumors

Anticancer Research

Volumn 34, Issue 6, 2014, Pages 2797-2800

  Gawthorpe, Stephanie ^a   Brown, James E ^b   Arif, Muhammad ^b   Nightingale, Peter ^c   Nevill, Alan ^d   Carmichael, Amtul R ^a  

^a RUSSELLS HALL HOSPITAL   (United Kingdom)

^b ASTON UNIVERSITY   (United Kingdom)

^c UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^d UNIVERSITY OF WOLVERHAMPTON   (United Kingdom)

Author keywords

Breast cancer; Heparanase; Lymph nodes; Tumor grade

Indexed keywords

CYCLOOXYGENASE 2; ESTROGEN RECEPTOR; HEPARANASE; BETA GLUCURONIDASE; PTGS2 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER SIZE; CANCER SURVIVAL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; METASTASIS POTENTIAL; PROTEIN EXPRESSION; BREAST TUMOR; CANCER GRADING; ENZYME IMMUNOASSAY; ENZYMOLOGY; FEMALE; FOLLOW UP; LYMPH NODE; METABOLISM; METASTASIS; MIDDLE AGED; PROGNOSIS; TUMOR GRADE; VERY ELDERLY;

BREAST CANCER; HEPARANASE; LYMPH NODES; TUMOR GRADE;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CYCLOOXYGENASE 2; FEMALE; FOLLOW-UP STUDIES; GLUCURONIDASE; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM GRADING; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84906311517     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Nakajima M, Irimura T, Di Ferrante N and Nicolson GL: Metastatic melanoma cell heparanase. Characterization of heparan sulfate degradation fragments produced by B16 melanoma endoglucuronidase. J Biol Chem 259(4): 2283-2290, 1984.
2. Wang Z, Xu H, Jiang L, Zhou X, Lu C and Zhang X: Positive association of heparanase expression with tumor invasion and lymphatic metastasis in gastric carcinoma. Mod Pathol 18(2): 205-211, 2005.
3. Ilan N, Elkin M and Vlodavsky I: Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis. Int J Biochem Cell Biol 38(12): 2018-2039, 2006.
4. Parish CR, Freeman C and Hulett MD: Heparanase: a key enzyme involved in cell invasion. Biochim Biophys Acta 1471(3): M99-108, 2001.
5. Rickles FR: If heparanase is the answer, what is the question? J Thromb Haemost 4(3): 557-559, 2006.
6. Vlodavsky I, Friedmann Y, Elkin M, Aingorn H, Atzmon R, Ishai-Michaeli R, Bitan M, Pappo O, Peretz T, Michal I, Spector L and Pecker I: Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis. Nat Med 5(7): 793-802, 1999.
7. Vlodavsky I, Goldshmidt O, Zcharia E, Atzmon R, Rangini-Guatta Z, Elkin M, Peretz T and Friedmann Y: Mammalian heparanase: involvement in cancer metastasis, angiogenesis and normal development. Semin Cancer Biol 12(2): 121-129, 2002.
8. Costa C, Soares R, Reis-Filho JS, Leitao D, Amendoeira I and Schmitt FC: Cyclo-oxygenase 2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer. J Clin Pathol 55(6): 429-434, 2002.
9. Imada T, Matsuoka J, Nobuhisa T, Okawa T, Murata T, Tabuchi Y, Shirakawa Y, Ohara N, Gunduz M, Nagatsuka H, Umeoka T, Yamamoto Y, Nakajima M, Tanaka N and Naomoto Y: COX-2 induction by heparanase in the progression of breast cancer. Int J Mol Med 17(2): 221-228, 2006.
10. Maxhimer JB, Quiros RM, Stewart R, Dowlatshahi K, Gattuso P, Fan M, Prinz RA and Xu X: Heparanase-1 expression is associated with the metastatic potential of breast cancer. Surgery 132(2): 326-333, 2002.
11. Denkert C, Winzer KJ and Hauptmann S: Prognostic impact of cyclooxygenase-2 in breast cancer. Clin Breast Cancer 4(6): 428-433, 2004.
12. Subbaramaiah K, Chung WJ and Dannenberg AJ: Ceramide regulates the transcription of cyclooxygenase-2. Evidence for involvement of extracellular signal-regulated kinase/c-Jun N-terminal kinase and p38 mitogen-activated protein kinase pathways. J Biol Chem 273(49): 32943-32949, 1998.
13. Porter GJ, Evans AJ, Pinder SE, James JJ, Cornford EC, Burrell HC, Chan SY, Cheung KL and Robertson JF: Patterns of metastatic breast carcinoma: influence of tumour histological grade. Clin Radiol 59(12): 1094-1098, 2004.
14. Gotte M and Yip GW: Heparanase, hyaluronan, and CD44 in cancers: a breast carcinoma perspective. Cancer Res 66(21): 10233-10237, 2006.
15. Elkin M, Cohen I, Zcharia E, Orgel A, Guatta-Rangini Z, Peretz T, Vlodavsky I and Kleinman HK: Regulation of heparanase gene expression by estrogen in breast cancer. Cancer Res 63(24): 8821-8826, 2003.
16. Liu ZZ, Zhang HW, Wei B and Cui SD: Correlation of expression of heparanase to angiogenesis and prognosis of breast cancer. Ai Zheng 23(11): 1342-1345, 2004.
17. Zcharia E, Metzger S, Chajek-Shaul T, Friedmann Y, Pappo O, Aviv A, Elkin M, Pecker I, Peretz T and Vlodavsky I: Molecular properties and involvement of heparanase in cancer progression and mammary gland morphogenesis. J Mammary Gland Biol Neoplasia 6(3): 311-22, 2001.
18. Gomes AM, Stelling MP and Pavao MS: Heparan sulfate and heparanase as modulators of breast cancer progression. Biomed Res Int 2013: 852093, 2013.
19. Shackney SE and Silverman JF: Molecular evolutionary patterns in breast cancer. Adv Anat Pathol 10(5): 278-290, 2003.
20. Barth RJ Jr., Danforth DN Jr., Venzon DJ, Straus KL, d'Angelo T, Merino MJ and Gerber L: Level of axillary involvement by lymph node metastases from breast cancer is not an independent predictor of survival. Arch Surg 126(5): 574-577, 1991.
21. Cohen I, Maly B, Simon I, Meirovitz A, Pikarsky E, Zcharia E, Peretz T, Vlodavsky I and Elkin M: Tamoxifen induces heparanase expression in estrogen receptor-positive breast cancer. Clin Cancer Res 13(14): 4069-4077, 2007.
22. Barth A, Craig PH and Silverstein MJ: Predictors of axillary lymph node metastases in patients with T1 breast carcinoma. Cancer 79(10): 1918-1922, 1997.
23. Sun L, Yu DH, Sun SY, Zhuo SC, Cao SS and Wei L: Expressions of ER, PR, HER-2, COX-2, and VEGF in primary and relapsed/metastatic breast cancers. Cell Biochem Biophys 68(3): 511-516, 2014.